EURETINA

LIGHTSITE II study: Photobiomodulation treatment improves vision in eyes with dry AMD

September 12, 2021

During a presentation at the EURETINA 2021 Virtual Congress, Prof. Ben Burton detailed how dry AMD patients treated with photobiomodulation therapy have seen improvements in best-corrected visual acuity 9 months after treatment.

Brolucizumab injection improves vision in eyes with neovascular AMD

September 11, 2021

In a presentation at the EURETINA 2021 Virtual Congress, Dr Cristina Cristian noted that an injection of brolucizumab treatment in patients with neovascular age-related macular degeneration led to a median improvement in visual acuity (VA) of 10.5 letters and the drug was well-tolerated.